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Modern extracorporeal life support [veno-venous (vv) or 
veno-arterial extracorporeal membrane oxygenation (vaE-
CMO)] is generating increasing interest throughout the 
world. Despite the significantly increasing use of ECMO 
in recent years, in-hospital mortality remains high [1]. 
Furthermore, clear inclusion criteria for ECMO treatment 
are lacking, resulting in a call for further investigation [2], 
especially in specific areas such as vaECMO for rescue 
cardiopulmonary resuscitation, where the rate of survival 
with good neurologic recovery is poor in some settings [3].
With increasing use of ECMO as a technology to main-
tain, or even replace, basic biological functions [4], the 
question we will hear sometimes at bedside rounds is: ‘Do 
we want to continue ECMO if recovery with any quality 
of life is unlikely or perhaps impossible?’ [5]. While the 
broad application of new technologies like ECMO no 
doubt saves lives in many cases, these innovations create a 
new thinking about medical ethics [6]. Traditional ethical 
principles (autonomy, beneficence, nonmaleficence, jus-
tice) may not be easily applied to some ECMO patients: 
What is the meaning of “well-being” in situations where, 
for instance, patients on ECMO are not recovering and 
there are no other therapies to offer? In recent years, we 
have increasingly engaged with families in “shared deci-
sion-making”. In a recent survey of physicians’ attitudes 
toward decision-making authority for the initiation and 
withdrawal of vaECMO [7], the majority of physicians 
who self-reported as very specialized in vaECMO treat-
ment felt that physicians should have the right to discon-
tinue vaECMO over a family’s objection. Such a point of 
view cannot be left unchallenged. Shared decision-making 
brings its own set of ethical challenges in ECMO patients:
Who decides? When ECMO no longer seems to pro-
vide hope of recovery, should the decision to discontinue 
ECMO be a shared decision, or should clinicians alone 
decide when to stop? Shared decisions may enhance 
autonomy. Yet, there is a downside to deferring these 
decisions to a patient or surrogate. The burden of the 
decision, in the setting of great medical complexity, may 
overwhelm the very people we are trying to help; their 
experience of the decision-making process may be laced 
with feelings of profound guilt, anger or fear [6].
Can we enact our decision? In the event that the cessa-
tion of ECMO will result in immediately linked cardio-
circulatory collapse and death, some surrogates—or even 
some members of the intensive care staff—may experi-
ence those situations as a profound burden.
Are intensivists prepared to address ethical questions 
related to this evolving technology? A new context for 
common ethical questions and new issues per se are 
associated with novel technologies like ECMO [6], and 
here we offer recommendations based on literature [6, 8, 
9] and our own experiences:
‘Close guidance’ of the relatives:
The intensivist must help ensure, preemptively, that the 
ECMO treatment is consistent with patient preferences 
and goals of care. In contrast to other organ-replacement 
procedures (mechanical ventilation or renal replacement 
therapy) ECMO creates unique challenges. For instance, 
vaECMO, by providing circulatory support, may at times 
preclude circulatory death despite evident cardiac death. 
This creates confusion about the state of the patient; is 
she alive or is she dead? This is more than a technical 
matter. It raises complex issues regarding the futility of 
ongoing therapy. If further cardiac mechanical support is 
not being offered, should ECMO simply be withdrawn? 
Discussions with the surrogates must consider autonomy 
in decision-making and yet pass the fine line between 
therapy with a goal and a device that is merely preventing 
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the dying process from taking place. It is crucial to strike 
the right balance to inform decision-making.
‘Preventive ethics’ [5, 6]:
 – Daily interdisciplinary rounds—from the beginning of 
ECMO treatment—should carefully address the fol-
lowing: Is ECMO potentially a bridge to recovery, a 
guarantee of a status quo, or just prohibiting dying?
  – Advance care planning (ACP) [10]: A process in which 
relatives receive information early after initiation of 
ECMO about the ongoing therapeutic process, the 
prognosis and specific consequences of continuation 
or discontinuation of ECMO. ACP should include a 
discussion of values, appropriate goals and fears; the 
patient’s preferences should be articulated, and ACP 
may include a written prospective contract with surro-
gates among possible future scenarios (e.g., discontinu-
ation of ECMO in irreversible organ failure).
 – Conflicts about treatment benefits and burdens, and 
discussions on futility may arise in patients on ECMO. 
A mandatory ethics consultation policy [11], as an 
example, will increase the frequency and quality of 
ethics consultant–physician interaction, and increased 
awareness among physicians and nurses of potential 
ethics support. A precondition for such a policy is the 
institution’s presence of a well-established ethics con-
sultation service with consultants who understand the 
rudiments of ECMO technologies and the associated 
ethical issues. Mandatory palliative care consultation 
[12] might also be considered, especially in cases of 
great medical complexity and prognostic uncertainty.
Support by spiritual and palliative care providers:
Emotional support of patients and surrogates is essen-
tial with a focus on listening carefully to their concerns, 
and on providing technical details of the patient’s course. 
Their reactions may be anger as an expression of helpless-
ness, confrontation as a manifestation of extreme stress. 
Clinicians must not take such expressions personally, 
but place them in context and react with empathy to the 
greatest extent possible. Furthermore the utility of explor-
ing spiritual issues with critically ill patients who have 
difficulty communicating, using a chaplain-led picture-
guided tool for spiritual care [13], was demonstrated.
In our approach to such patients, ECMO is different 
from other forms of life support, since our ability to push 
the limits of life and stave off death (even if only tem-
porarily) is that much greater and therefore that much 
more fraught with potential ethical complications. In 
that context, the rapid development and use of ECMO is 
an illustration of the fact that new technologies in medi-
cine deserve carefully crafted approaches to medical eth-
ics [6, 8, 9]. Furthermore these changes need systematic 
research to better understand the demands of patients, 
relatives, and medical staff, and to propose solutions for 
potentially complex ethical dilemmas.
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